東華大學圖書館 |

語系: 繁體中文

說明(常見問題)

回圖書館首頁

手機版館藏查詢

登入

回首頁

切換: 標籤 | MARC模式 | ISBD

Ex vivo engineering of the tumor mic...

Aref, Amir R.

FindBook

Google Book

Amazon

博客來

Ex vivo engineering of the tumor microenvironment

紀錄類型:	書目-電子資源 : Monograph/item
正題名/作者:	Ex vivo engineering of the tumor microenvironment/ edited by Amir R. Aref, David Barbie.
其他作者:	Aref, Amir R.
出版者:	Cham :Springer International Publishing : : 2017.,
面頁冊數:	ix, 135 p. :ill., digital ;24 cm.
內容註:	1.Introduction to Ex Vivo Cancer Models -- 2.Patient-derived Xenografts in Oncology -- 3.Organoid Culture: Applications in Development and Cancer -- 4. Microfluidics and future of cancer diagnostics -- 5.Advancing techniques and insights in circulating tumor cell (CTC) research -- 6.The Cancer Secretome -- 7.An overview of the tumor microenvironments and future of cancer therapy.
Contained By:	Springer eBooks
標題:	Cancer - Molecular aspects. -
電子資源:	http://dx.doi.org/10.1007/978-3-319-45397-2
ISBN:	9783319453972

Ex vivo engineering of the tumor microenvironment
Ex vivo engineering of the tumor microenvironment[electronic resource] /edited by Amir R. Aref, David Barbie. - Cham :Springer International Publishing :2017. - ix, 135 p. :ill., digital ;24 cm. - Cancer drug discovery and development,2196-9906. - Cancer drug discovery and development..

1.Introduction to Ex Vivo Cancer Models -- 2.Patient-derived Xenografts in Oncology -- 3.Organoid Culture: Applications in Development and Cancer -- 4. Microfluidics and future of cancer diagnostics -- 5.Advancing techniques and insights in circulating tumor cell (CTC) research -- 6.The Cancer Secretome -- 7.An overview of the tumor microenvironments and future of cancer therapy.

This volume will outline how to recreate the tumor microenvironment, to culture primary tumors without the need for developmental priming factors, and to deliver targeted therapeutics in a manner that recapitulates pharmacokinetics in vivo. Much of what may be learned from this volume will aid in understanding many aspects of the enhanced study of tumor cell biology in a physiologic context, open new avenues for drug screening and biomarker development, and accelerate the preclinical evaluation of novel personalized medicine strategies for patients in real time.

ISBN: 9783319453972

Standard No.: 10.1007/978-3-319-45397-2doiSubjects--Topical Terms:

661419
Cancer
--Molecular aspects.

LC Class. No.: RC268.4

Dewey Class. No.: 616.994

Ex vivo engineering of the tumor microenvironment
LDR:01947nmm a2200325 a 4500 001 2089281
003 DE-He213
005 20170703152220.0
006 m d
007 cr nn 008maaau
008 171013s2017 gw s 0 eng d
020 $a 9783319453972 $q (electronic bk.)
020 $a 9783319453958 $q (paper)
024 7 $a 10.1007/978-3-319-45397-2 $2 doi
035 $a 978-3-319-45397-2
040 $a GP $c GP
041 0 $a eng
050 4 $a RC268.4
072 7 $a MJCL $2 bicssc
072 7 $a MED062000 $2 bisacsh
082 0 4 $a 616.994 $2 23
090 $a RC268.4 $b .E96 2017
245 0 0 $a Ex vivo engineering of the tumor microenvironment $h [electronic resource] / $c edited by Amir R. Aref, David Barbie.
260 $a Cham : $b Springer International Publishing : $b Imprint: Humana Press, $c 2017.
300 $a ix, 135 p. : $b ill., digital ; $c 24 cm.
490 1 $a Cancer drug discovery and development, $x 2196-9906
505 0 $a 1.Introduction to Ex Vivo Cancer Models -- 2.Patient-derived Xenografts in Oncology -- 3.Organoid Culture: Applications in Development and Cancer -- 4. Microfluidics and future of cancer diagnostics -- 5.Advancing techniques and insights in circulating tumor cell (CTC) research -- 6.The Cancer Secretome -- 7.An overview of the tumor microenvironments and future of cancer therapy.
520 $a This volume will outline how to recreate the tumor microenvironment, to culture primary tumors without the need for developmental priming factors, and to deliver targeted therapeutics in a manner that recapitulates pharmacokinetics in vivo. Much of what may be learned from this volume will aid in understanding many aspects of the enhanced study of tumor cell biology in a physiologic context, open new avenues for drug screening and biomarker development, and accelerate the preclinical evaluation of novel personalized medicine strategies for patients in real time.
650 0 $a Cancer $x Molecular aspects. $3 661419
650 0 $a Tumors $x Molecular aspects. $3 1005414
650 1 4 $a Biomedicine. $3 890831
650 2 4 $a Cancer Research. $3 891172
700 1 $a Aref, Amir R. $3 3219761
700 1 $a Barbie, David. $3 3219762
710 2 $a SpringerLink (Online service) $3 836513
773 0 $t Springer eBooks
830 0 $a Cancer drug discovery and development. $3 1565408
856 4 0 $u http://dx.doi.org/10.1007/978-3-319-45397-2
950 $a Medicine (Springer-11650)